SynthesisFrontiers in oncology2025
Knowledge mapping of global trends in DNA damage repair-related breast cancer research: a bibliometric study.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer remains one of the leading causes of cancer-related morbidity and mortality among women worldwide. Recent advancements in our understanding of DNA damage repair (DDR) mechanisms have shed light on their specific role in the pathogenesis, progression, treatment resistance, and prognosis of breast cancer. In this study, we conducted a bibliometric study to map the global trends in DDR-related breast cancer research. Methodology: A search of publications on DDR in breast cancer from 1990 to 2024 was conducted using the Web of Science Core Collection. A comprehensive bibliometric analysis of the data was performed using CiteSpace, VOSviewer, and Bibliometrix. Additionally, for clinical trial data, the databases ClinicalTrials.gov (https://www.clinicaltrials.gov) and the WHO International Clinical Trials Registry Platform (ICTRP) (https://trialsearch.who.int) were queried. Results: The results revealed a continuous and steady growth in the number of articles published in this area over the past three decades and showed that the USA had produced the highest number of publications in this field, while Harvard University had published the largest number of articles. Jonkers, Jos was found to be the most published author, with 39 documents. Analysis of the journals showed that Conclusion: Overall, this study provides valuable insights into the current research achievements, latest advancements, and emerging global trends in DNA damage repair-related breast cancer research. With sustained clinical focus, more high-quality investigations combining DDR inhibitors with other treatment modalities are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.